Cargando…

mRNA vaccines and clinical research in Africa - From hope to reality

Detalles Bibliográficos
Autor principal:	Saied, AbdulRahman A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364941/ https://www.ncbi.nlm.nih.gov/pubmed/35963578 http://dx.doi.org/10.1016/j.ijsu.2022.106833

Ejemplares similares

COVID-19 in Africa: between hope and reality
por: Ntoumi, Francine, et al.
Publicado: (2021)

Africa is going to develop their own health capabilities for future challenges – Correspondence
por: Saied, AbdulRahman A.
Publicado: (2022)

Besides human booster doses: Could vaccinating highly susceptible animals to SARS-CoV-2 be the needed urgent strategic step?
por: Saied, AbdulRahman A.
Publicado: (2022)

COVID-19 vaccination in animals: A strategy for combating the global outbreak
por: Choudhary, Om Prakash, et al.
Publicado: (2022)

SARS-CoV-2 and Influenza A virus: Dual diagnostics and vaccines
por: Saied, AbdulRahman A., et al.
Publicado: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Should not airborne transmission be ignored in the 2022 monkeypox outbreak?
por: Saied, AbdulRahman A.
Publicado: (2022)

Ring vaccination for monkeypox containment: Strategic implementation and challenges
por: Choudhary, Om Prakash, et al.
Publicado: (2022)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
por: Zauche, Lauren H., et al.
Publicado: (2021)

Reply: Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Heo, Sang Taek
Publicado: (2022)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
por: Esteban, Ignasi, et al.
Publicado: (2021)

Vaccines: hope vs reality
por: Lawton, Graham
Publicado: (2020)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

Severe bullous drug reaction after COVID‐19 mRNA vaccination
por: Irmer, Marie Luise, et al.
Publicado: (2022)

Addressing the Cold Reality of mRNA Vaccine Stability
por: Crommelin, Daan J.A., et al.
Publicado: (2021)

Clinical development of mRNA therapies against solid tumors
por: Wu, Dawei, et al.
Publicado: (2023)

Paleovirology of monkeypox virus: Egyptian animal mummies should be in focus
por: Saied, AbdulRahman A, et al.
Publicado: (2022)

Gambian children’s deaths due to contaminated cough syrups are a mutual responsibility
por: Saied, AbdulRahman A., et al.
Publicado: (2023)

A Tale of 2 mRNA Vaccines: The Spring of Hope, The Winter of Despair
por: Witberg, Guy, et al.
Publicado: (2022)

Russo-Ukrainian war amid the COVID-19 pandemic: Global impact and containment strategy
por: Dhawan, Manish, et al.
Publicado: (2022)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Exacerbation of Lupus Erythematosus Panniculitis After Administration of COVID-19 mRNA Vaccine
por: Avcı, Ceylan, et al.
Publicado: (2022)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

COVID‐19 mRNA‐1273 vaccine induces production of vaccine‐induced immune thrombotic thrombocytopenia antibodies
por: Padmanabhan, Anand, et al.
Publicado: (2022)

Monkeypox: An extra burden on global health
por: Saied, AbdulRahman A., et al.
Publicado: (2022)

Rare Skin Reactions after mRNA Vaccination, Similar to Jones–Mote Basophil Responses
por: Askenase, Philip W.
Publicado: (2021)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0nkt81t02vafebrkis4vokrq89